DNAH11 Gene Primary Ciliary Dyskinesia Type 7 NGS Genetic DNA Test
Comprehensive Genetic Testing for Respiratory Health
The DNAH11 Gene Primary Ciliary Dyskinesia Type 7 NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying genetic mutations associated with Primary Ciliary Dyskinesia (PCD) Type 7. This sophisticated genetic analysis utilizes next-generation sequencing technology to examine the DNAH11 gene, which plays a critical role in the proper functioning of cilia – the microscopic, hair-like structures that line the respiratory tract and other organs.
What Does This Test Measure?
This comprehensive genetic test specifically targets the DNAH11 gene to identify mutations that disrupt normal ciliary function. The test detects:
- Point mutations and small insertions/deletions in the DNAH11 gene
- Genetic variations affecting dynein arm assembly in cilia
- Mutations responsible for impaired mucociliary clearance
- Genetic markers associated with ciliary dyskinesia and related respiratory complications
Who Should Consider This Test?
This genetic test is particularly recommended for individuals experiencing:
- Chronic respiratory infections from early childhood
- Persistent sinusitis and nasal congestion
- Recurrent middle ear infections and hearing loss
- Chronic cough with sputum production
- Bronchiectasis or abnormal lung function
- Neonatal respiratory distress syndrome
- Infertility issues in males due to impaired sperm motility
- Family history of Primary Ciliary Dyskinesia
- Situs inversus (organs on opposite sides of the body)
Clinical Benefits of DNAH11 Genetic Testing
Undergoing the DNAH11 gene test provides numerous clinical advantages:
- Accurate Diagnosis: Confirms or rules out Primary Ciliary Dyskinesia Type 7 with high precision
- Personalized Treatment: Enables targeted management strategies for respiratory symptoms
- Genetic Counseling: Provides valuable information for family planning and genetic risk assessment
- Early Intervention: Facilitates proactive management to prevent long-term complications
- Comprehensive Care: Guides multidisciplinary approach involving ENT specialists, pulmonologists, and genetic counselors
Understanding Your Test Results
Your DNAH11 gene test results will be carefully interpreted by our genetic specialists:
- Positive Result: Indicates the presence of pathogenic mutations in the DNAH11 gene, confirming Primary Ciliary Dyskinesia Type 7 diagnosis
- Negative Result: Suggests no detectable mutations in the DNAH11 gene, though other genetic causes of PCD may need consideration
- Variant of Uncertain Significance: Identifies genetic changes whose clinical significance requires further investigation
- Carrier Status: Determines if you carry one copy of a mutated gene, which may be important for family planning
Test Pricing Information
| Test Name | Regular Price | Discount Price |
|---|---|---|
| DNAH11 Gene Primary Ciliary Dyskinesia Type 7 NGS Genetic DNA Test | $700 USD | $500 USD |
Nationwide Testing Availability
We have conveniently located branches across the United States, serving patients in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our state-of-the-art genetic testing facilities ensure consistent, high-quality results regardless of your location.
Take Control of Your Respiratory Health Today
Don’t let chronic respiratory symptoms compromise your quality of life. The DNAH11 Gene Primary Ciliary Dyskinesia Type 7 NGS Genetic DNA Test provides the clarity needed for proper diagnosis and effective treatment planning. Our experienced genetic counselors and medical specialists are ready to guide you through the testing process and help interpret your results.
Call us now at +1(267) 388-9828 to schedule your appointment or book your test online. Take the first step toward understanding your genetic health and achieving better respiratory outcomes.
